Christian Gruber is research group leader and Associate Professor at the Medical University of Vienna (Austria). He studied Biochemistry at the University of Tübingen (Germany) and received a Ph.D. in Molecular Biosciences from The University of Queensland (Australia). The research focus of his team is to study biological function, structure-activity relationship and pharmacological mechanism of nature-derived peptides isolated from plants and invertebrates (e.g., peptide hormones, neuropeptides and peptide toxins), and the development of novel peptide therapeutics. Other functions: He is Associate Editor of the British Journal of Pharmacology, Editorial Board Member of the Journal of Medicinal Chemistry and Chief Scientific Advisor to the company Cyxone (Sweden), which is currently exploring a macrocyclic peptide for use in multiple sclerosis based on a patent portfolio from his research. Further information: http://www.meduniwien.ac.at/pharmakologie/ms/